Abstract
Reactive oxygen species (ROS) play important roles in the pathogenesis of cardiovascular disorders, such as hypertension. The isozymes of NAD(P)H oxidases are source of ROS in the organism, and increased activity of them has been associated to the hypertension. The development of inhibitors of NAD(P)H oxidase and antioxidant drugs is recommended for the treatment of hypertension. In this …